Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)

ClinicalTrials.gov ID: NCT03444870

Public ClinicalTrials.gov record NCT03444870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 11:42 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study of Gantenerumab in Patients With Early (Prodromal to Mild) Alzheimer's Disease

Study identification

NCT ID
NCT03444870
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
1,053 participants

Conditions and interventions

Interventions

  • Gantenerumab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 5, 2018
Primary completion
Dec 27, 2022
Completion
Feb 16, 2023
Last update posted
Jan 29, 2024

2018 – 2023

United States locations

U.S. sites
33
U.S. states
18
U.S. cities
32
Facility City State ZIP Site status
Center for Neurosciences Tucson Arizona 85718
Global Clinical Trials; Irvine, CA Irvine California 92614
Sutter Medical Group, Neurology Sacramento California 95816
Syrentis Clinical Research Santa Ana California 92705
California Neuroscience Research Medical Group, Inc Sherman Oaks California 91403
Research Center for Clinical Studies, Inc. Norwalk Connecticut 06851
JEM Research LLC Atlantis Florida 33462
Bradenton Research Center Bradenton Florida 34205
Brain Matters Research, Inc. Delray Beach Florida 33445
Alzheimer?s Research and Treatment Center Wellington Florida 33414
Columbus Memory Center Columbus Georgia 31909
Center for Advanced Research & Education Gainesville Georgia 30501
Southern Illinois University, School of Medicine Springfield Illinois 62702
Fort Wayne Neurological Center Fort Wayne Indiana 46805
Via Christi Research Wichita Kansas 67214
Precise Research Centers Flowood Mississippi 39232
University of Mississippi Medical Center Jackson Mississippi 39216
Advanced Memory Research Institute of NJ Toms River New Jersey 08755
Neurological Associates of Long Island, PC Lake Success New York 11042
Columbia University Medical Center New York New York 10032
Ohio State University; College of Medicine Columbus Ohio 43210
Abington Neurological Associates Abington Pennsylvania 19001
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046
Drexel University; College of Medicine Philadelphia Pennsylvania 19102
Coastal Neurology Port Royal South Carolina 29935
Senior Adults Specialty Research Austin Texas 78757
Neurology Consultants of Dallas; Research Department Dallas Texas 75243
Wasatch Clinical Research, LLC Salt Lake City Utah 84107
University of Virginia Charlottesville Virginia 22906
Sentara Neurology Specialists Norfolk Virginia 23507
Neurological Associates, Inc. Richmond Virginia 23229
National Clinical Research Inc.-Richmond Richmond Virginia 23294
UW Wisconsin-Madison Madison Wisconsin 53705

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 139 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03444870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 29, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03444870 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →